Search Results - STOMACH CANCER

Refine Results
  1. 1
  2. 2

    Biomarkers of gastric atrophy at stomach cancer by A. V. Belkovets, S. A. Kurilovich., Yu. I. Ragino, L. V. Scherbakova, O. B. Cheremisina, N. V. Cherdyntseva, N. A. Andryushina, M. I. Voyevoda

    “…Atrophic gastritis (AG), being the basic premalignant condition for the stomach cancer (SC), is commonly diagnosed and screened for by noninvasive biomarkers (pepsinogens, gastrin-17), however the data on those biomarkers at SC is inconsistent. …”
    Get full text
    Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Complex analysis of lung cancer and stomach cancer risk factors by Lezhnin Vladimir, Polzik Eugene, Kazantsev Vladimir

    Published in Archive of Oncology (2003-01-01)
    “…METHODS: We examined 200 lung cancer cases, 206 stomach cancer cases, and 213 controls, all residents of Tula. …”
    Get full text
    Article
  8. 8

    Stomach cancer risk factors: the modern concept by V. M. Khomyakov, A. D. Yermoshina, S. S. Pirogov, A. B. Ryabov

    “…To present the systematic overview of the stomach cancer risk factors to determine prophylactic measures and to define high-risk groups of population that can be included to the screening programs. …”
    Get full text
    Article
  9. 9

    Neoadjuvant chemotherapy in localized resectable stomach cancer by Min-Hee Ryu

    Published in Korean Journal of Clinical Oncology (2014-06-01)
    “…The Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer and Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer phase III trials have demonstrated that systemic adjuvant chemotherapy can significantly improve recurrence-free survival (RFS) and overall survival (OS) after D2 dissection with absolute survival benefit of 10% to 15% compared with surgery alone. …”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

Search Tools: